CDKL5 deficiency disorder: progressive brain atrophy may be part of the syndrome

Nicola Specchio1, Marina Trivisano1, Matteo Lenge2

  • 1Clinical and Experimental Neurology, Bambino Gesù Children's Hospital IRCCS, Rome 00165, Italy.

Insights

Brain imaging in Cyclin-Dependent Kinase-Like 5 (CDKL5) deficiency disorder (CDD) reveals significant brain volume reduction, particularly in white matter and temporal regions. These changes may stem from the disorder

Area of Science:

  • Neuroscience
  • Genetics
  • Radiology

Background:

  • Cyclin-Dependent Kinase-Like 5 (CDKL5) deficiency disorder (CDD) is a severe neurodevelopmental condition.
  • While the clinical features of CDD are known, systematic analysis of neuroimaging findings is lacking.
  • Understanding brain structure in CDD is crucial for diagnosis and management.

Purpose of the Study:

  • To systematically analyze neuroimaging features in patients with CDKL5 deficiency disorder (CDD).
  • To investigate potential correlations between brain structure, epilepsy severity, and head circumference in CDD.
  • To identify progressive changes in brain morphology associated with CDD pathogenesis.

Main Methods:

  • Retrospective analysis of 35 brain MRI scans from 22 unrelated CDD patients.
  • Qualitative assessment of brain structures (supratentorial and cerebellar atrophy).
  • Quantitative volumetric analysis of whole brain, white matter, gray matter, and cortical surface area.

Main Results:

  • Early-life MRIs (first year) were often unremarkable.
  • Later MRIs (after 24 months) revealed supratentorial and cerebellar atrophy in a significant proportion of patients.
  • Quantitative analysis showed significant whole brain volume reduction (-17.7%), white matter reduction (-25.7%), and cortical surface area reduction (-18.0%), particularly in temporal regions.

Conclusions:

  • CDKL5 deficiency disorder is associated with progressive brain volume reduction, affecting both gray and white matter.
  • Observed structural changes may be linked to CDD pathogenesis, severe epilepsy, or a combination of factors.
  • Further prospective studies are required to elucidate the underlying mechanisms of these neuroimaging findings.

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
604
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
525
Long-term Depression01:03

Long-term Depression

Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
2.6K
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K
Disorders of the Nervous Tissue01:28

Disorders of the Nervous Tissue

Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
1.4K
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage kidney disease (ESKD). At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate...
41